← Back to news
GrantRSSThursday, April 30, 2026 · April 30, 2026

MJFF and ASAP invest $261M in global network for Parkinson’s research

WHY IT MATTERS

This funding expansion means more research teams globally are working on personalized Parkinson's treatments, which could lead to therapies that work better for your specific type of disease rather than generic treatments.

Two major Parkinson's disease research organizations are giving $261 million to fund 32 new research teams around the world. This money will help scientists better understand what causes Parkinson's disease and develop treatments tailored to individual patients instead of one-size-fits-all approaches.

Aligning Science Across Parkinson’s (ASAP) and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) are together investing $261 million in new grant funding to better understand what drives Parkinson’s disease and to accelerate the development of more personalized therapies. The monies will expand the Collaborative Research Network (CRN), supporting 32 new global teams working […] The post MJFF and ASAP invest $261M in global network for Parkinson’s research appe

Read the original at rss
parkinson's diseaseresearch fundingpersonalized medicineglobal research networkdrug development

Related conditions

Hereditary late-onset Parkinson diseaseAllergic bronchopulmonary aspergillosisMethionine adenosyltransferase I/III deficiency

Related news

Advocacyrss · May 4, 2026
MJFF raises almost $2M in NYC Parkinson’s Unity Walk
The Michael J. Fox Foundation held a 1.2-mile walk in Central Park on April 25, 2026, where over 3,000 people participat